Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.58 |
| ▸ | NPY1R | P25929 | 9/20 | 0.58 |
| ▸ | NPY2R | P49146 | 6/20 | 0.58 |
| ▸ | TFPI | P10646 | 1/20 | 0.58 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3870837 | 0.97 | NPY4R (0.62) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL31277748 | 0.90 | NPY4R (0.58) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL30522316 | 0.90 | NPY4R (0.58) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL31430937 | 0.88 | NPY4R (0.68) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL31437674 | 0.87 | NPY4R (0.57) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL29789581 | 0.86 | NPY4R (0.52) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL30601532 | 0.86 | NPY4R (0.54) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL31437671 | 0.86 | NPY4R (0.57) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL30522315 | 0.86 | NPY4R (0.54) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL30618025 | 0.86 | NPY4R (0.54) | NPY4RNPY5RNPY1RNPY2RTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962697-B2 | Bioreponsive polymers | INTERFACE BIOLOGICS INC. (CA) | 2015-02-24 | — | — | US | disclosed |
| US-20100041771-A1 | Bioreponsive Polymers | INTERFACE BIOLOGICS, INC. | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041771-A1 | Bioreponsive Polymers | PEPD, PREP, DNPEP | NPY4R 1902/4885NPY5R 2786/4885NPY1R 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.